Endometrial hyperplasia and endometrial polyps: clinical and anamnestic characteristics of women
https://doi.org/10.23946/2500-0764-2023-8-4-16-23
Abstract
Aim. To study the clinical and anamnestic characteristics of patients with endometrial hyperplasia (EH) and endometrial polyps (PE).
Material and Methods. a retrospective study was conducted, which included 267 sick women of reproductive and perimenopausal age who sought gynecological care at «Euromed» in 2022-23, who, before receiving the examination results, were diagnosed with N92 - heavy, frequent and irregular menstruation. Depending on the results of the pathomorphological examination, the patients were divided into 3 groups: group A included 89 patients with GE; group B – 99 women with PE; Group B (control) included 79 patients in whom endometrial pathology was excluded.
Results. Among all women who came to the clinic with heavy menstrual bleeding, 33.3% had GE, 37.1% had PE, 29.6% had BUN-O ovulatory dysfunction. GE without atypia was detected in 72 (80.9%) cases of group A, GE with atypia – in 7 (19.1%), in group B PE was diagnosed in 91 (91.9%) cases, PE with atypia – in 28 (8.1%).
In group B, in 22 (27.8%) cases, the endometrium was identified in the proliferation phase, in 57 (72.2%) cases, the endometrium was identified in the phase of incomplete secretion.
Conclusion. Women with GE are characterized by early menarche, absence of pregnancies and childbirth during life associated with the woman’s choice, contraception, endocrine diseases, obesity, polycystic ovary syndrome, ovarian tumors, heavy bleeding with clots during menstruation, menstruation for more than 8 days, chronic iron deficiency anemia. Women with endometrial polyps are characterized by arterial hypertension, uterine fibroids, adenomyosis, infertility, dysmenorrhea, chronic endometritis, a history of cervicitis and vaginitis; clinical manifestations include intermenstrual bleeding.
About the Authors
E. N. Kravchenko
Omsk State Medical University
Russian Federation
Russian Federation
Elena N. Kravchenko - MD, DSc, Professor, Professor of the Department of Obstetrics and Gynecology No. 1, Omsk State Medical University.
12, Lenina Street, Omsk, 644043
E. V. Lautenschleger
Multidisciplinary Center for Modern Medicine «Euromed»
Russian Federation
Russian Federation
Elena V. Lautenschleger - obstetrician-gynecologist of the highest qualification category, doctor at Multidisciplinary center for modern medicine «Euromed».
21B, Lukashevicha Street, Omsk, 644119
References
1. Ring KL, Mills AM, Modesitt SC. Endometrial Hyperplasia. Obstet Gynecol.2022;140(6):1061-1075. https://doi.org/10.1097/AOG.00000000000049892
2. Kubyshkin AV, Aliev LL, Fomochkina II, Kovalenko YP, Litvinova SV, Filonenko TG, Lomakin NV, Kubyshkin VA, Karapetian OV. Endometrial hyperplasia-related inflammation: its role in the development and progression of endometrial hyperplasia. Inflamm Res. 2016;65(10):785-794. https://doi.org/10.1007/s00011-016-0960-z
3. Nees LK, Heublein S, Steinmacher S, Juhasz-Böss I, Brucker S, Tempfer CB, Wallwiener M. Endometrial hyperplasia as a risk factor of endometrial cancer. Arch Gynecol Obstet. 2022;306(2):407-421. https://doi.org/10.1007/s00404-021-06380-5
4. Hutt S, Tailor A, Ellis P, Michael A, Butler-Manuel S, Chatterjee J. The role of biomarkers in endometrial cancer and hyperplasia: a literature review. Acta Oncol. 2019;58(3):342-352. https://doi.org/10.1080/0284186X.2018.1540886
5. Russo M, Newell JM, Budurlean L, Houser KR, Sheldon K, Kesterson J, Phaeton R, Hossler C, Rosenberg J, DeGraff D, Shuman L, Broach JR, Warrick JI. Mutational profile of endometrial hyperplasia and risk of progression to endometrioid adenocarcinoma. Cancer. 2020;126(12):2775-2783. https://doi.org/10.1002/cncr.32822
6. Gabidullina RI, Smirnova GA, Nuhbala FR, Valeeva EV, Orlova YuI, Shakirov AA. Hyperplastic processes of the endometrium: modern tactics of patient management. Gynecology. 2019;21(6):53-58. https://doi.org/10.26442/20795696.2019.6.190472
7. Chandra V, Kim JJ, Benbrook DM, Dwivedi A, Rai R. Therapeutic options for management of endometrial hyperplasia. J Gynecol Oncol. 2016;27(1):e8. https://doi.org/10.3802/jgo.2016.27.e8
8. Sanderson PA, Critchley HO, Williams AR, Arends MJ, Saunders PT. New concepts for an old problem: the diagnosis of endometrial hyperplasia. Hum Reprod Update. 2017;23(2):232-254. https://doi.org/10.1093/humupd/dmw042
9. Yang JH, Chen CD, Chen SU, Yang YS, Chen MJ. Factors Influencing the Recurrence Potential of Benign Endometrial Polyps after Hysteroscopic Polypectomy. PLoS One. 2015;10(12):e0144857. https://doi.org/10.1371/journal.pone.0144857
10. Tanos V, Berry KE, Seikkula J, Abi Raad E, Stavroulis A, Sleiman Z, Campo R, Gordts S. The management of polyps in female reproductive organs. Int J Surg. 2017;43:7-16. https://doi.org/10.1016/j.ijsu.2017.05.012
11. Al Chami A, Saridogan E. Endometrial polyps and subfertility. J Obstet Gynaecol India. 2017;67(1):9-14. https://doi.org/10.1007/s13224-016-0929-4
12. Pereira AK, Garcia MT, Pinhiero W, Ejzenberg D, Soares Jr JM, Baracat EC. What is the influence of cyclooxygenase-2 on postmenopausal endometrial polyps? Climacteric. 2015;18(4):498-502. https://doi.org/10.3109/13697137.2014.966240
13. Indraccolo U, Di Iorio R, Matteo M, Corona G, Greco P, Indraccolo SR. The pathogenesis of endometrial polyps: a systematic semi-quantitative review. Eur J Gynaecol Oncol. 2013;34(1):5-22.
14. Cicinelli E, Bettocchi S, de Ziegler D, Loizzi V, Cormio G, Marinaccio M, Trojano G, Crupano FM, Francescato R, Vitagliano A, Resta L. Chronic Endometritis, a Common Disease Hidden Behind Endometrial Polyps in Premenopausal Women: First Evidence From a Case-Control Study. J Minim Invasive Gynecol. 2019;26(7):1346-1350. https://doi.org/10.1016/j.jmig.2019.01.012
15. Topcu HO, Erkaya S, Guzel AI, Kokanali MK, Sarikaya E, Muftuoglu KH, Doganay M. Risk factors for endometrial hyperplasia concomitant endometrial polyps in pre- and post-menopausal women. Asian Pac J Cancer Prev. 2014;15(13):5423-5425. https://doi.org/10.7314/apjcp.2014.15.13.5423
16. Orazov MR, Mikhaleva LM, Poymanova OF, Mullina IA. Pathogenesis mechanisms of endometrial polyps in women of reproductive age: a literature review. Gynecology. 2022;24(4):246-250. (In Russ). https://doi.org/10.26442/20795696.2022.4.201807
17. Clarke MA, Long BJ, Sherman ME, Lemens MA, Podratz KC, Hopkins MR, Ahlberg LJ, Mc Guire LJ, Laughlin-Tommaso SK, Bakkum-Gamez JN, Wentzensen N. Risk assessment of endometrial cancer and endometrial intraepithelial neoplasia in women with abnormal bleeding and implications for clinical management algorithms. Am J Obstet Gynecol. 2020;223(4):549.e1-549.e13. https://doi.org/10.1016/j.ajog.2020.03.032
18. Salamova KK, Saprykina LV, Ramazanova AM, Mil'dzihova ZT, Stolyarova EV. Clinical characteristic of women with endometrial hyperplasia. Russian journal of woman and child health rmzh. 2021;4(2):124-129. (In Russ). https://doi.org/10.32364/2618-8430-2021-4-2-124-129
19. Hickey M, Balen A. Menstrual disorders in adolescence: investigation and management. Hum Reprod Update. 2003;9(5):493-504. https://doi.org/10.1093/humupd/dmg038
20. Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, Piltonen T, Norman RJ; International PCOS Network. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril. 2018;110(3):364-379. https://doi.org/10.1016/j.fertnstert.2018.05.004
21. Munro MG, Critchley HOD, Fraser IS, Committee FMD. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. Int J Gynecol Obstet. 2018;143(3):393-408. https://doi.org/10.1002/ijgo.12666.
Review
For citations:
Kravchenko E.N., Lautenschleger E.V. Endometrial hyperplasia and endometrial polyps: clinical and anamnestic characteristics of women. Fundamental and Clinical Medicine. 2023;8(4):16-23. (In Russ.) https://doi.org/10.23946/2500-0764-2023-8-4-16-23
Views:
282
Email this article 